Since the sequence of the human genome was published some 20 years ago, omics strategies have enabled the generation of detailed molecular signatures of cancers and their subtypes.
https://www.drugtargetreview.com/article/23631/2-17-tavassoli/
Review: biomarkers towards personalised therapy in cancer